BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takeuchi T, Hayashi M, Tamita T, Nomura Y, Kojima N, Mitani A, Takeda T, Hitaka K, Kato Y, Kamitani M, Mima M, Toki H, Ohkubo M, Nozoe A, Kakinuma H. Discovery of Aryloxyphenyl-Heptapeptide Hybrids as Potent and Selective Matrix Metalloproteinase-2 Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis. J Med Chem 2022;65:8493-510. [PMID: 35687819 DOI: 10.1021/acs.jmedchem.2c00613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Takeuchi T, Nomura Y, Tamita T, Nishikawa R, Kakinuma H, Kojima N, Hitaka K, Tamura Y, Kamitani M, Mima M, Nozoe A, Hayashi M. Discovery of TP0597850: A Selective, Chemically Stable, and Slow Tight-Binding Matrix Metalloproteinase-2 Inhibitor with a Phenylbenzamide-Pentapeptide Hybrid Scaffold. J Med Chem 2023;66:822-36. [PMID: 36595440 DOI: 10.1021/acs.jmedchem.2c01698] [Reference Citation Analysis]
2 Sanyal S, Amin SA, Banerjee P, Gayen S, Jha T. A review of MMP-2 structures and binding mode analysis of its inhibitors to strategize structure-based drug design. Bioorganic & Medicinal Chemistry 2022;74:117044. [DOI: 10.1016/j.bmc.2022.117044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]